You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Budesonide, Formoterol Fumarate Drug Combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD Trial in Worldwide (Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate, Treatment B: Budesonide and

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate
  • +2 more
  • Torrance, California
  • +25 more
Sep 28, 2023

Moderate Asthma Trial in São Paulo (Administration of investigation drug, Administration of comparator)

Not yet recruiting
  • Moderate Asthma
  • Administration of investigation drug
  • Administration of comparator
  • São Paulo, Brazil
    Eurofarma Laboratorios S.A
Feb 9, 2023

Asthma Trial in Medford (Budesonide 80 µg and Formoterol Fumarate Dihydrate 4.5 µg, Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation

Recruiting
  • Asthma
  • Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg
  • +2 more
  • Medford, Oregon
    Velocity Clinical Research
May 6, 2022

Quality of Life With Administration of Fixed Combination of

Completed
  • Asthma
  • Quality of Life
  • Budesonide/Formoterol treated patients
  • Athens, Mesogion Ave. 152, Greece
    7th Pulmonary Dept, Athens Chest Hospital
Sep 7, 2022

COPD Trial in Glendale (Treatment A: BGF MDI HFO, Treatment B: BGF MDI HFA)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Treatment A: BGF MDI HFO
  • Treatment B: BGF MDI HFA
  • Glendale, California
    Research Site
Jan 18, 2023

COPD (COPD) Trial in Germany (BFF, Symbicort Turbuhaler)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • BFF
  • Symbicort Turbuhaler
  • Frankfurt/Main, Germany
  • +3 more
Feb 21, 2022

COPD (COPD) Trial in Guelph (BGF MDI HFO 320/14.4/9.6µg, BGF MDI HFA 320/14.4/9.6 µg, Placebo MDI HFA)

Not yet recruiting
  • COPD (Chronic Obstructive Pulmonary Disease)
  • BGF MDI HFO 320/14.4/9.6μg
  • +2 more
  • Guelph, Ontario, Canada
    Research Site
Oct 4, 2023

Real-life After Initation of Treatment With Trixeo

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • BGF (budesonide/glycopyrrolate/formoterol fumarate)
  • Acquaviva delle Fonti, Italy
  • +23 more
May 8, 2023

COPD Trial in Brooklyn (Treatment A (BGF MDI HFO with oral activated charcoal), Treatment B (BGF MDI HFA with oral activated

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Treatment A (BGF MDI HFO with oral activated charcoal)
  • Treatment B (BGF MDI HFA with oral activated charcoal)
  • Brooklyn, Maryland
    Research Site
Aug 11, 2022

COPD Trial in Paris (Beclomethasone 100 µg plus formoterol 6 µg (CHF1535) pMDI, Budesonide 200 µg plus formoterol 6 µg DPI,

Completed
  • Chronic Obstructive Pulmonary Disease
  • Beclomethasone 100 µg plus formoterol 6 µg (CHF1535) pMDI
  • +2 more
  • Paris, France
    Thomas Similowski
Oct 28, 2021

Asthma Trial in United States (Budesonide/Formoterol fumarate dihydrate, Symbicort, Placebo)

Completed
Has Results
  • Asthma
  • Budesonide/Formoterol fumarate dihydrate
  • +2 more
  • Birmingham, Alabama
  • +94 more
Aug 1, 2022

Asthma Trial in Rotterdam (Budesonide/Formoterol fumarate dihydrate)

Recruiting
  • Asthma
  • Budesonide/Formoterol fumarate dihydrate
  • Rotterdam, Zuid-Holland, Netherlands
    Franciscus Gasthuis & Vlietland
Apr 14, 2023

Symptom and Quality of Life in COPD by

Recruiting
  • Pulmonary Disease, Chronic Obstructive
    • Nagoya, Aichi, Japan
    • +16 more
    Jan 17, 2023

    Asthma in Children Trial in France (Budesonide Formoterol Drug Combination, nebulisation of terbutaline)

    Recruiting
    • Asthma in Children
    • Budesonide Formoterol Drug Combination
    • nebulisation of terbutaline
    • Boulogne-Billancourt, France
    • +7 more
    Sep 6, 2021

    Asthma Trial in Worldwide (BFF MDI 160/9.6 µg BID (320/19.2µg/day), BD MDI 160 µg BID (320 µg/day))

    Recruiting
    • Asthma
    • BFF MDI 160/9.6 μg BID (320/19.2μg/day)
    • BD MDI 160 μg BID (320 μg/day)
    • Huntington Beach, California
    • +52 more
    Mar 9, 2023

    Asthma Trial in Worldwide (BFF MDI 320/9.6 µg, BFF MDI 160/9.6 µg, BD MDI 320 µg)

    Recruiting
    • Asthma
    • BFF MDI 320/9.6 μg
    • +3 more
    • Saraland, Alabama
    • +121 more
    Aug 22, 2022

    Real-world, 52-week Prospective Study to Capture Reasons for

    Not yet recruiting
    • Pulmonary Disease, Chronic Obstructive (COPD)
    • Budesonide Glycopyrronium bromide Formoterol fumarate pressurized Metered Dose Inhaler
    • (no location specified)
    Jun 13, 2023

    Exercise Performance Trial in Copenhagen (Symbicort, Formoterol, Placebo)

    Not yet recruiting
    • Exercise Performance
    • Copenhagen, Denmark
      August Krogh Building
    Oct 23, 2023

    COPD (COPD) Trial in Glendale (Treatment A, Treatment B, Treatment C)

    Completed
    Has Results
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Treatment A
    • +2 more
    • Glendale, California
      Research Site
    Apr 20, 2022

    Asthma Trial (Formoterol Fumarate DPI, Mometasone Furoate/Formoterol Fumarate MDI (ex-actuator) without spacer, Mometasone

    Completed
    Has Results
    • Asthma
    • Formoterol Fumarate DPI
    • +5 more
    • (no location specified)
    Feb 7, 2022

    Asthma Trial (Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID, Mometasone Furoate MDI (MF MDI), Formoterol

    Completed
    Has Results
    • Asthma
    • Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID
    • +3 more
    • (no location specified)
    Feb 7, 2022

    Asthma Trial (mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID, Mometasone furoate MDI (MF MDI) 200 mcg,

    Completed
    Has Results
    • Asthma
    • mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID
    • +3 more
    • (no location specified)
    Feb 7, 2022

    Asthma Trial (Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI, Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5

    Completed
    Has Results
    • Asthma
    • Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI
    • Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5 mcg MDI
    • (no location specified)
    Feb 7, 2022

    Pulmonary Disease, Chronic Obstructive Trial in London (CHF1535, Formoterol fumarate)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • London, United Kingdom
      UCL Medical School
    Oct 28, 2021

    COPD Trial in Berlin-Spandau (CHF5993, CHF1535, Matched )

    Recruiting
    • Chronic Obstructive Pulmonary Disease
    • Berlin-Spandau, Berlin Spandauer Damm, Germany
      PAREXEL International GmbH Early Phase Clinical Unit Berlin
    Jan 21, 2022